Noticias de ANTX_US

Noticias del mercado

Últimas noticias sobre ANTX_US — 85 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: ANTX_US ✕ 85 resultados
23/03/2026 ANTX_US — Stock Titan
AN2 Therapeutics (ANTX) CFO swaps higher-priced options for $3.91 grants
23/03/2026 ANTX_US — Stock Titan
AN2 Therapeutics (ANTX) reprices stock options for board director
23/03/2026 ANTX_US — Stock Titan
AN2 Therapeutics (ANTX) director receives repriced stock option awards
23/03/2026 ANTX_US — Stock Titan
CEO option repricing at AN2 Therapeutics (ANTX) detailed in Form 4 filing
23/03/2026 ANTX_US — Stock Titan
AN2 Therapeutics (ANTX) director reprices fully vested options at $3.91 strike
23/03/2026 ANTX_US — Stock Titan
AN2 Therapeutics (ANTX) officer sees large option repricing, no share sales
23/03/2026 ANTX_US — Stock Titan
AN2 Therapeutics (ANTX) director’s 44,466 stock options repriced to $3.91
23/03/2026 ANTX_US — Stock Titan
Director at AN2 Therapeutics (ANTX) has stock options repriced
21/03/2026 ANTX_US — The Globe and Mail
AN2 Therapeutics Reprices Stock Options to Enhance Retention
20/03/2026 ANTX_US — TipRanks
AN2 Therapeutics Reprices Stock Options to Enhance Retention
20/03/2026 ANTX_US — Investing.com
AN2 Therapeutics reduces stock option exercise prices for executives and directors
20/03/2026 ANTX_US — Stock Titan
AN2 Therapeutics (ANTX) cuts exercise price on executive and employee options to $3.91
18/03/2026 ANTX_US — BioSpace
AN2 Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business and Scientific Highlights
17/03/2026 ANTX_US — Yahoo Finance
AN2 Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business and Scientific Highlights
17/03/2026 ANTX_US — Business Wire
AN2 Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business and Scientific Highlights
11/03/2026 ANTX_US — Benzinga
AN2 Therapeutics Stock Cools Off After 90% Rally
11/03/2026 ANTX_US — Minichart
AN2 Therapeutics Secures $40 Million in Private Placement Financing to Advance Boron-Based Drug Pipeline
10/03/2026 ANTX_US — TradingView
AN2 Therapeutics Raises $40 Million in Private Placement of Shares and Pre-Funded Warrants
10/03/2026 ANTX_US — TipRanks
AN2 Therapeutics Announces $40 Million Private Placement Financing
09/03/2026 ANTX_US — Yahoo Finance
AN2 Therapeutics Announces $40 Million Private Placement Financing

Página 4 de 5

keyboard_arrow_up